GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
201
c/glp1canada·posted 1 months ago by u/piotr_nascimento

why does nobody talk about Canada

Formulary

why does nobody talk about Canada — that is what I am asking, and I have already read the wiki twice.

Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing.

Nothing here is medical or legal advice. The pharmacist and the prescriber are the people who can act, and both are faster than a forum.

Read the special authorization criteria and wrote the application against them line by line. Approved first time after a previous refusal.

Research-use-only material is not approved for human use and nothing here should be read as a recommendation to use it.

259 up / 58 down82% upvoted19 commentsid 1hss1b6 Jun 2026

19 comments

16 in this archive, depth 4

best — the order this archive was captured in

u/diego_sorensen35 points·1 months ago

Quantity limits restrict how much may be dispensed in a period even where coverage exists. They are a distinct barrier and require a distinct request.

replysharereportpermalink
u/emil_barros10 points·1 months ago

Not convinced. A rejected claim at the counter is not a denied authorization and the next step differs.

replysharereportpermalink
u/piotr_nascimentoOP-26 points·1 months ago

Not convinced.

Adding the fastest step — ask the pharmacist. They can usually check in minutes.

replysharereportpermalink
u/sigrid_kaufmann1 point·1 months ago

the same product can be covered in one province and not the next

replysharereportpermalink
u/ayesha_radich21 points·1 months ago

Quantity limits restrict how much may be dispensed in a period even where coverage exists.

Agreed — write the application against the published criteria rather than around them.

replysharereportpermalink
[removed]25 points·1 months ago

[removed by moderator]

replysharereportpermalink
u/karim_restrepo7 points·1 months ago

the exception drug status route exists in several provinces

replysharereportpermalink
u/amara_haddad5 points·1 months ago

The pharmacist sorted in five minutes what the phone line had not managed in a fortnight.

replysharereportpermalink
u/piotr_nascimentoOP11 points·1 months ago

Has your plan renewed since the last time you applied?

replysharereportpermalink
u/gradient_goblin14 points·1 months ago

Agreed on keeping every form and date. When something goes wrong the paper trail is the whole case.

replysharereportpermalink
u/ahmed_abubakar29 points·1 months ago

National regulatory approval establishes that a product may be sold. Whether any plan pays for it is a separate decision, and public drug plans are administered provincially.

replysharereportpermalink
u/formulary_fighterMOD12 points·1 months ago

Pharmacy staff name removed. The pharmacy can stay in a pricing post.

replysharereportpermalink
u/rina_ferreira14 points·1 months ago

Cosigning on quantity limits. They stop as many people as outright denials do and get discussed far less.

replysharereportpermalink
u/enzo_ferrari9 points·1 months ago

Kept every form and reference number. When they had no record of a submission, I did.

replysharereportpermalink
u/adaeze_batista3 points·1 months ago

ask the pharmacy what the cash price is, it varies

replysharereportpermalink
u/vikram_asante15 points·1 months ago

I would not read one pharmacy’s cash price as the going rate. The spread is real.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.